ProPublica looks at the Rx-$ nexus

Share this article:

Non-profit journo outfit ProPublica found that at least 17 of the top 20 prescribers of beta blocker Bystolic in Medicare's prescription drug program in 2010 had also been paid by Forest for promotional talks.

Nine of the top 10 prescribers of Alzheimer's drug Exelon received money from Novartis, and eight of the top 10 for J&J painkiller Nucynta were paid speakers, as were six of the top 10 for Pfizer antidepressant Pristiq.

The data used came from the Dollars for Docs tool, which includes payments from 15 drug makers, as well as its new ­Prescriber Checkup, which has data on prescribing in Medicare Part D.
Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.

Email Newsletters